Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Biodesix, Inc. (BDSX)
USD21.36
+0.23 (+1.09%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
2970 Wilderness Place 80301
Boulder, CO, US
Boulder, CO, US
CEO
Scott Hutton
Website
biodesix.com
IPO
2020-10-28
CIK 1439725 ISIN US09075X2071
Description
Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT). These assessments enable clinicians to evaluate the risk of lung cancer in patients with suspicious nodules, aiding in the reclassification of malignancy risk and guiding appropriate treatment pathways. Beyond risk assessment, Biodesix offers additional lung cancer diagnostics such as GeneStrat ddPCR, which detects specific tumor mutations, and VeriStrat, which gauges the patient's immune system status. Both are crucial for establishing prognosis and informing treatment plans. Another offering is the GeneStrat NGS (Next-Generation Sequencing) test, a rapid, blood-based sequencing solution providing results within 72 hours. Through a partnership with Bio-Rad Laboratories, Inc., Biodesix also provides COVID-19 testing services under its Biodesix WorkSafe program, featuring the Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 Total Ab test, an antibody assay for detecting a B-cell immune response indicating recent or prior infection. Furthermore, the company extends its expertise to biopharmaceutical companies, offering diagnostic and clinical research services, alongside clinical trial testing. It also actively discovers, develops, and commercializes companion diagnostics. Originally incorporated as Elston Technologies, Inc. in 2005, Biodesix, Inc. maintains its headquarters in Boulder, Colorado.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD21.36
+0.23 (+1.09%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
74.4K
Beta
0.52
Float Shares
2.96M
Free Float %
39.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.16% | +7.83% | +22.70% | +48.62% | +102.64% | +136.91% | +124.06% | -46.30% | -93.81% | -93.71% | -93.71% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
21.36
Low
3.00
-86.0%
Consensus
8.67
-59.4%
Median
3.00
-86.0%
High
20.00
-6.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
20.00
-6.4%
|
| All Time | 3 |
8.67
-59.4%
|
Quality scores
Altman Z-Score
-6.18
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+24.1% ★ Q1'26: +42.3% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+29.2% Q1'26: +49.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-33.5% Q1'26: -40.4% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-31.1% Q1'26: -24.2% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-53.6% Q1'26: -44.9% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+16.5% Q1'26: +31.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-3.33× Q1'26: -3.74× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
45.56M
est: 33.42M (+36.3%)
|
54.51M
est: 54.68M (-0.3%)
|
38.21M
est: 39.31M (-2.8%)
|
49.09M
est: 60.90M (-19.4%)
|
71.32M
est: 70.77M (+0.8%)
|
88.50M
est: 86.02M (+2.9%)
|
110.98M
110.88M – 111.08M
+29.0% YoY
|
132.72M
132.07M – 133.38M
+19.6% YoY
|
155.60M
154.58M – 156.68M
+17.2% YoY
|
182.10M
180.91M – 183.36M
+17.0% YoY
|
198.00M
196.71M – 199.37M
+8.7% YoY
|
| EBITDA |
-20.84M
est: -21.88M (+4.7%)
|
-35.47M
est: -35.81M (+0.9%)
|
-51.53M
est: -25.74M (-100.2%)
|
-37.10M
est: -37.32M (+0.6%)
|
-29.22M
est: -43.36M (+32.6%)
|
-21.88M
est: -52.70M (+58.5%)
|
-68.00M
-68.06M – -67.94M
-29.0% YoY
|
-81.32M
-81.72M – -80.92M
-19.6% YoY
|
-95.34M
-96.00M – -94.72M
-17.2% YoY
|
-111.57M
-112.35M – -110.85M
-17.0% YoY
|
-121.32M
-122.16M – -120.52M
-8.7% YoY
|
| EBIT |
-23.75M
est: -23.96M (+0.9%)
|
-38.65M
est: -39.20M (+1.4%)
|
-57.38M
est: -28.18M (-103.6%)
|
-42.61M
est: -41.10M (-3.7%)
|
-34.67M
est: -47.77M (+27.4%)
|
-27.55M
est: -58.05M (+52.5%)
|
-74.90M
-74.97M – -74.84M
-29.0% YoY
|
-89.58M
-90.02M – -89.13M
-19.6% YoY
|
-105.02M
-105.74M – -104.33M
-17.2% YoY
|
-122.90M
-123.75M – -122.10M
-17.0% YoY
|
-133.63M
-134.56M – -132.76M
-8.7% YoY
|
| Net Income |
-31.35M
est: -165.95M (+81.1%)
|
-43.16M
est: -204.51M (+78.9%)
|
-65.45M
est: -188.34M (+65.3%)
|
-52.15M
est: -3.39M (-1,437.6%)
|
-42.93M
est: -52.60M (+18.4%)
|
-35.27M
est: -38.88M (+9.3%)
|
-22.81M
-23.01M – -22.61M
+41.3% YoY
|
-13.76M
-13.88M – -13.64M
+39.7% YoY
|
-10.53M
-11.55M – -9.51M
+23.5% YoY
|
-4.49M
-4.53M – -4.45M
+57.3% YoY
|
-2.34M
-2.36M – -2.32M
+47.9% YoY
|
| SGA |
34.86M
est: 38.78M (-10.1%)
|
50.52M
est: 63.45M (-20.4%)
|
61.46M
est: 45.61M (+34.8%)
|
67.39M
est: 73.39M (-8.2%)
|
80.45M
est: 85.28M (-5.7%)
|
87.55M
est: 103.65M (-15.5%)
|
133.74M
133.62M – 133.86M
+29.0% YoY
|
159.94M
159.15M – 160.73M
+19.6% YoY
|
187.51M
186.28M – 188.81M
+17.2% YoY
|
219.44M
218.01M – 220.96M
+17.0% YoY
|
238.60M
237.04M – 240.25M
+8.7% YoY
|
| EPS |
-6.48
est: -25.60 (+74.7%)
|
-31.60
est: -31.54 (-0.2%)
|
-31.00
est: -28.90 (-7.3%)
|
-12.80
est: -0.45 (-2,750.7%)
|
-6.60
est: -6.96 (+5.2%)
|
-4.67
est: -5.15 (+9.3%)
|
-3.02
-3.05 – -2.99
+41.3% YoY
|
-1.82
-1.84 – -1.81
+39.7% YoY
|
-1.40
-1.53 – -1.26
+23.4% YoY
|
-0.60
-0.60 – -0.59
+57.3% YoY
|
-0.31
-0.31 – -0.31
+47.9% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Canaccord Genuity | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-19.04M
OE per share TTM
-2.34
Owner's Yield
-12.24%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
28.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
6
Total invested
18.47M
Insider transactions (90d)
0
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lawrence T. Kennedy, Jr. | 14.85M | 19.40% | 18.3K | 14.83M | 18.3K | 14.83M | IN | — | 2023-01-13 | ↗ |
| 2 | Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 | 9.15M | 12.00% | — | 9.15M | — | 9.15M | OO | — | 2023-01-13 | ↗ |
| 3 | John Patience | 7.15M | 9.30% | 471.5K | 6.68M | 471.5K | 6.68M | IN | — | 2022-12-01 | ↗ |
| 4 | Joseph Edelman | 6.67M | 5.60% | — | 6.67M | — | 6.67M | IN | Delaware | 2024-05-13 | ↗ |
| 5 | Perceptive Advisors LLC | 6.67M | 5.60% | — | 6.67M | — | 6.67M | IA | Delaware | 2024-05-13 | ↗ |
| 6 | Perceptive Credit Advisors LLC | 6.67M | 5.60% | — | 6.67M | — | 6.67M | OO | Delaware | 2024-05-13 | ↗ |
| 7 | Jack W. Schuler | 6.01M | 22.80% | — | 6.01M | — | 6.01M | IN | — | 2020-11-09 | ↗ |
| 8 | Jack W. Schuler Living Trust | 5.67M | 21.60% | — | 5.67M | — | 5.67M | OO | — | 2020-11-09 | ↗ |
| 9 | (. | 5.57M | 7.10% | — | — | 5.57M | — | IN | United States | 2023-03-21 | ↗ |
| 10 | 27-4413262 | 5.57M | 7.10% | — | — | 5.57M | — | OO | Maryland | 2023-03-21 | ↗ |
| 11 | Perceptive Credit Holdings IV, LP | 5.54M | 4.60% | — | 5.54M | — | 5.54M | PN | Delaware | 2024-05-13 | ↗ |
| 12 | John Patience Living Trust dated 7/23/1993 | 4.55M | 5.90% | — | 4.55M | — | 4.55M | OO | — | 2022-12-01 | ↗ |
| 13 | Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 | 4.36M | 5.70% | — | 4.36M | — | 4.36M | OO | — | 2023-01-13 | ↗ |
| 14 | Matthew Strobeck | 2.40M | 6.10% | 2.40M | — | 2.40M | — | IN | — | 2022-04-18 | ↗ |
| 15 | IND Funding LLC | 2.19M | 8.20% | — | 2.19M | — | 2.19M | OO | Delaware | 2021-06-01 | ↗ |
| 16 | Life Sciences Alternative Funding LLC | 2.19M | 8.20% | — | 2.19M | — | 2.19M | OO | Delaware | 2021-06-01 | ↗ |
| 17 | Robert Cawthorn | 2.00M | 7.40% | 70.3K | 1.93M | 70.3K | 1.93M | HC, IN | Guernsey | 2021-08-23 | ↗ |
| 18 | Manlia Limited | 1.93M | 7.20% | — | 1.93M | — | 1.93M | OO | Guernsey | 2021-08-23 | ↗ |
| 19 | Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 30-6 | 1.75M | 4.55% | — | 1.75M | — | 1.75M | OO | OR PLACE OF ORGANIZATION | 2022-04-12 | ↗ |
| 20 | Lair BDSX GRAT 2022-3.2 | 1.62M | 4.23% | — | 1.62M | — | 1.62M | OO | OR PLACE OF ORGANIZATION | 2022-04-12 | ↗ |
| 21 | PCOF EQ AIV IV, LP | 1.14M | 1.00% | — | 1.14M | — | 1.14M | PN | Delaware | 2024-05-13 | ↗ |
| 22 | Schuler Family Foundation | 277.8K | 1.10% | — | 277.8K | — | 277.8K | CO | — | 2020-11-09 | ↗ |
| 23 | KFDI-B LLC 26-3914642 | 166.7K | 0.43% | — | 166.7K | — | 166.7K | PN | OR PLACE OF ORGANIZATION | 2022-04-12 | ↗ |
| 24 | KFDI-B LLC | 166.7K | 0.20% | — | 166.7K | — | 166.7K | PN | — | 2023-01-13 | ↗ |
| 25 | Telemark Asset Management, LLC | 6.00 | 5.70% | — | 8.28M | — | 8.28M | IA, OO | Delaware | 2024-06-24 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
6
-20 vs prev Q
New positions
3
Closed positions
23
Increased
4
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | TELEMARK ASSET MANAGEMENT, LLC | 327.8K -86.3K (-20.8%) | 2.23M -897.4K (-28.7%) | 4.37% -1.151 pp | 0.22% -0.074 pp | USD7.55 -9.9% | 2 qtrs — |
| 2 | ABRDN PLC | 262.4K +262.4K (+100.0%) | 1.78M +1.8M (+100.0%) | 3.50% +3.499 pp | 0.00% +0.003 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 3 | VANGUARD GROUP INC | 192.1K +10.2K (+5.6%) | 1.31M -66.8K (-4.9%) | 2.56% +0.137 pp | 0.00% +0.000 pp | USD7.51 -9.5% | 2 qtrs — |
| 4 | — | 187.00 +187.0 (+100.0%) | 1.27M +1.3M (+100.0%) | 0.00% +0.003 pp | 0.00% +0.001 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 5 | MONASHEE INVESTMENT MANAGEMENT LLC | 112.3K +12.3K (+12.3%) | 763.9K +9.0K (+1.2%) | 1.50% +0.165 pp | 0.43% +0.054 pp | USD7.47 -9.0% | 2 qtrs — |
| 6 | PERCEPTIVE ADVISORS LLC | 108.7K +— (+0.0%) | 739.1K -81.5K (-9.9%) | 1.45% +0.000 pp | 0.01% -0.011 pp | USD7.55 -9.9% | 2 qtrs — |
| 7 | GSA CAPITAL PARTNERS LLP | 64.5K +16.1K (+33.4%) | 438.0K +73.0K (+20.0%) | 0.86% +0.215 pp | 0.04% +0.007 pp | USD7.36 -7.6% | 2 qtrs — |
| 8 | PERKINS CAPITAL MANAGEMENT INC | 44.8K -7.9K (-14.9%) | 304.5K -92.9K (-23.4%) | 0.60% -0.105 pp | 0.24% -0.108 pp | USD7.55 -9.9% | 2 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 42.5K +2.2K (+5.6%) | 288.8K -15.0K (-4.9%) | 0.57% +0.030 pp | 0.00% +0.000 pp | USD7.51 -9.5% | 2 qtrs — |
| 10 | BALYASNY ASSET MANAGEMENT L.P. | 33.0K -10.0K (-23.3%) | 224.5K -100.3K (-30.9%) | 0.44% -0.133 pp | 0.00% 0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 11 | TREXQUANT INVESTMENT LP | 27.5K +27.5K (+100.0%) | 187.3K +187.3K (+100.0%) | 0.37% +0.367 pp | 0.00% +0.002 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 12 | CITADEL ADVISORS LLC | 26.0K +26.0K (+100.0%) | 176.7K +176.7K (+100.0%) | 0.35% +0.347 pp | 0.00% +0.000 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 13 | BLACKROCK, INC. | 24.5K +— (+0.0%) | 166.4K -18.3K (-9.9%) | 0.33% +0.000 pp | 0.00% +0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 14 | STATE STREET CORP | 17.8K +2.4K (+15.6%) | 121.1K +4.8K (+4.1%) | 0.24% +0.032 pp | 0.00% +0.000 pp | USD7.45 -8.7% | 2 qtrs — |
| 15 | SHAY CAPITAL LLC | 16.1K +2.1K (+15.3%) | 109.8K +4.0K (+3.8%) | 0.22% +0.029 pp | 0.01% +0.002 pp | USD7.45 -8.7% | 2 qtrs — |
| 16 | DRW SECURITIES, LLC | 15.4K +15.4K (+100.0%) | 104.5K +104.5K (+100.0%) | 0.21% +0.205 pp | 0.00% +0.003 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12.5K -3.5K (-21.9%) | 85.0K -35.8K (-29.6%) | 0.17% -0.047 pp | 0.00% +0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 18 | NORTHERN TRUST CORP | 11.1K +11.1K (+100.0%) | 75.7K +75.7K (+100.0%) | 0.15% +0.149 pp | 0.00% +0.000 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 19 | CETERA INVESTMENT ADVISERS | 10.0K +10.0K (+100.0%) | 68.0K +68.0K (+100.0%) | 0.13% +0.133 pp | 0.00% +0.000 pp | USD6.80 +0.0% | 1 qtrs NEW |
| 20 | ALLWORTH FINANCIAL LP | 5.0K +— (+0.0%) | 33.8K -3.7K (-9.9%) | 0.07% +0.000 pp | 0.00% +0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 21 | TOWER RESEARCH CAPITAL LLC (TRC) | 193.00 -451.0 (-70.0%) | 1.3K -3.6K (-73.0%) | 0.00% -0.006 pp | 0.00% 0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 22 | FORTITUDE FAMILY OFFICE, LLC | 171.00 +— (+0.0%) | 1.2K -128.0 (-9.9%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 23 | BANK OF AMERICA CORP /DE/ | 143.00 +113.0 (+376.7%) | 972.00 +746.0 (+330.1%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD6.95 -2.2% | 2 qtrs — |
| 24 | GROUP ONE TRADING, L.P. | 100.00 +— (+0.0%) | 680.00 -75.0 (-9.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.55 -9.9% | 2 qtrs — |
| 25 | MORGAN STANLEY | 61.00 -15.0 (-19.7%) | 415.00 -159.0 (-27.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD7.52 -9.6% | 2 qtrs — |
| 26 | FMR LLC | 1.00 +— (+0.0%) | 7.00 -1.0 (-12.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.00 -2.9% | 2 qtrs — |
| 27 | ORACLE INVESTMENT MANAGEMENT INC | — -15.0K (-100.0%) | — -113.3K (-100.0%) | 0.00% -0.200 pp | 0.00% -0.071 pp | USD— | 2 qtrs SOLD |
| 28 | BARCLAYS PLC | — -1.0 (-100.0%) | — -8.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 29 | ROYAL BANK OF CANADA | — -8.9K (-100.0%) | — -67.0K (-100.0%) | 0.00% -0.119 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 30 | MILLENNIUM MANAGEMENT LLC | — -14.9K (-100.0%) | — -112.8K (-100.0%) | 0.00% -0.199 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 31 | SILVERARC CAPITAL MANAGEMENT, LLC | — -49.6K (-100.0%) | — -374.5K (-100.0%) | 0.00% -0.661 pp | 0.00% -0.051 pp | USD— | 2 qtrs SOLD |
| 32 | SPEARS ABACUS ADVISORS LLC | — -10.3K (-100.0%) | — -77.6K (-100.0%) | 0.00% -0.137 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 33 | CIBC PRIVATE WEALTH GROUP, LLC | — -1.5K (-100.0%) | — -11.1K (-100.0%) | 0.00% -0.020 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.03% | 372.8K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 696.0K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 7.1K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 19.4K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.4K | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 3.31M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 7.3K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 4.0K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 1.6K | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 175.94 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
37
Sells
37
Shares acquired
483.9K
Shares disposed
44.6K
Cash buys
3.00
Cash sales
15.00
Net activity
+439,371
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | PATIENCE JOHN | Director | M-Exempt | A | Common Stock | 1,361 | 0.00 | — | 24,022 | D | ↗ |
| 2026-02-23 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 211 | 12.78 | 2.7K | 1,586 | D | ↗ |
| 2026-02-23 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 556 | 12.78 | 7.1K | 10,359 | D | ↗ |
| 2026-02-23 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 535 | 12.78 | 6.8K | 9,819 | D | ↗ |
| 2026-02-23 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 1,490 | 12.78 | 19.0K | 48,767 | D | ↗ |
| 2026-02-23 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 535 | 12.78 | 6.8K | 16,231 | D | ↗ |
| 2026-02-20 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 563 | 0.00 | — | 1,689 | D | ↗ |
| 2026-02-20 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 1,528 | 0.00 | — | 4,582 | D | ↗ |
| 2026-02-20 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 1,469 | 0.00 | — | 10,354 | D | ↗ |
| 2026-02-20 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 4,844 | 0.00 | — | 50,257 | D | ↗ |
| 2026-02-20 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 1,469 | 0.00 | — | 4,406 | D | ↗ |
| 2026-02-10 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 101 | 10.08 | 1.0K | 1,234 | D | ↗ |
| 2026-02-10 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 540 | 10.08 | 5.4K | 9,387 | D | ↗ |
| 2026-02-10 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 584 | 10.08 | 5.9K | 8,885 | D | ↗ |
| 2026-02-10 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 3,559 | 10.08 | 35.9K | 45,413 | D | ↗ |
| 2026-02-10 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 941 | 10.08 | 9.5K | 15,297 | D | ↗ |
| 2026-02-09 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 28 | 0.00 | — | 0 | D | ↗ |
| 2026-02-09 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 68 | 0.00 | — | 0 | D | ↗ |
| 2026-02-09 | O'Kane Kieran | Officer | M-Exempt | D | Restricted Stock Units | 73 | 0.00 | — | 0 | D | ↗ |
| 2026-02-09 | Hutton Scott | Director / Officer | M-Exempt | D | Restricted Stock Units | 610 | 0.00 | — | 0 | D | ↗ |
| 2026-02-09 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 157 | 0.00 | — | 0 | D | ↗ |
| 2026-01-26 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 11.80 | 236.1K | 1,563,210 | I | ↗ |
| 2026-01-23 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 80,000 | 11.81 | 944.7K | 1,543,210 | I | ↗ |
| 2026-01-22 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 82,465 | 10.96 | 903.6K | 1,463,210 | I | ↗ |
| 2026-01-16 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 83 | 8.15 | 676.39 | 1,072 | D | ↗ |
| 2026-01-16 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 298 | 8.15 | 2.4K | 8,446 | D | ↗ |
| 2026-01-16 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 298 | 8.15 | 2.4K | 7,869 | D | ↗ |
| 2026-01-16 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 970 | 8.15 | 7.9K | 38,974 | D | ↗ |
| 2026-01-16 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 298 | 8.15 | 2.4K | 13,654 | D | ↗ |
| 2026-01-15 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 219 | 0.00 | — | 436 | D | ↗ |
| 2026-01-15 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 805 | 0.00 | — | 1,609 | D | ↗ |
| 2026-01-15 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 805 | 0.00 | — | 8,167 | D | ↗ |
| 2026-01-15 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 2,633 | 0.00 | — | 39,944 | D | ↗ |
| 2026-01-15 | Cowie Robin Harper | Officer | M-Exempt | A | Common Stock | 805 | 0.00 | — | 13,952 | D | ↗ |
| 2026-01-05 | PATIENCE JOHN | Director | M-Exempt | A | Common Stock | 1,143 | 0.00 | — | 22,661 | D | ↗ |
| 2026-01-02 | Vazquez Chris | Officer | A-Award | A | Stock Options (Right to Buy) | 12,000 | 6.46 | 77.5K | 12,000 | D | ↗ |
| 2026-01-02 | Strobeck Matthew | Director | A-Award | A | Stock Options (Right to Buy) | 6,354 | 6.46 | 41.0K | 6,354 | D | ↗ |
| 2026-01-02 | Pestano Gary Anthony | Officer | A-Award | A | Stock Options (Right to Buy) | 26,000 | 6.46 | 168.0K | 26,000 | D | ↗ |
| 2026-01-02 | PATIENCE JOHN | Director | A-Award | A | Restricted Stock Units | 5,443 | 0.00 | — | 5,443 | D | ↗ |
| 2026-01-02 | O'Kane Kieran | Officer | A-Award | A | Stock Options (Right to Buy) | 27,000 | 6.46 | 174.4K | 27,000 | D | ↗ |
| 2026-01-02 | MASSARANY HANY | Director | A-Award | A | Stock Options (Right to Buy) | 6,354 | 6.46 | 41.0K | 6,354 | D | ↗ |
| 2026-01-02 | Kennedy Lawrence T. Jr | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 6,354 | 6.46 | 41.0K | 6,354 | D | ↗ |
| 2026-01-02 | Kayyem Jon Faiz | Director | A-Award | A | Restricted Stock Units | 5,443 | 0.00 | — | 5,443 | D | ↗ |
| 2026-01-02 | Hutton Scott | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 97,000 | 6.46 | 626.6K | 97,000 | D | ↗ |
| 2026-01-02 | Franchi Jean M. | Director | A-Award | A | Stock Options (Right to Buy) | 6,354 | 6.46 | 41.0K | 6,354 | D | ↗ |
| 2026-01-02 | Cowie Robin Harper | Officer | A-Award | A | Stock Options (Right to Buy) | 29,000 | 6.46 | 187.3K | 29,000 | D | ↗ |
| 2025-11-10 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 31 | 0.00 | — | 29 | D | ↗ |
| 2025-11-10 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 23 | 7.62 | 175.26 | 7,939 | D | ↗ |
| 2025-11-10 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 25 | 7.62 | 190.50 | 7,362 | D | ↗ |
| 2025-11-10 | Hutton Scott | Director / Officer | M-Exempt | D | Restricted Stock Units | 611 | 0.00 | — | 610 | D | ↗ |
| 2025-11-10 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 158 | 0.00 | — | 157 | D | ↗ |
| 2025-09-30 | PATIENCE JOHN | Director | M-Exempt | A | Common Stock | 1,144 | 0.00 | — | 21,518 | D | ↗ |
| 2025-09-19 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 142,045 | 7.04 | 1,000.0K | 1,380,745 | I | ↗ |
| 2025-09-18 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 3,056 | 6.17 | 18.9K | 1,238,700 | I | ↗ |
| 2025-09-17 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 15,317 | 6.04 | 92.6K | 1,235,644 | I | ↗ |
| 2025-08-29 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 3,488,372 | 0.43 | 1.50M | 24,406,546 | I | ↗ |
| 2025-08-13 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 228 | 0.42 | 94.92 | 18,375 | D | ↗ |
| 2025-08-13 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 442 | 0.42 | 184.00 | 157,878 | D | ↗ |
| 2025-08-13 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 476 | 0.42 | 198.16 | 140,065 | D | ↗ |
| 2025-08-13 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 3,772 | 0.42 | 1.6K | 728,824 | D | ↗ |
| 2025-08-13 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 988 | 0.42 | 411.30 | 250,794 | D | ↗ |
| 2025-08-12 | Vazquez Chris | Officer | M-Exempt | A | Common Stock | 602 | 0.00 | — | 18,603 | D | ↗ |
| 2025-08-12 | Pestano Gary Anthony | Officer | M-Exempt | A | Common Stock | 1,379 | 0.00 | — | 158,320 | D | ↗ |
| 2025-08-12 | O'Kane Kieran | Officer | M-Exempt | D | Restricted Stock Units | 1,489 | 0.00 | — | 2,979 | D | ↗ |
| 2025-08-12 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 12,212 | 0.00 | — | 732,596 | D | ↗ |
| 2025-08-12 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 3,157 | 0.00 | — | 6,313 | D | ↗ |
| 2025-07-01 | MASSARANY HANY | Director | M-Exempt | A | Common Stock | 26,368 | 0.00 | — | 310,135 | D | ↗ |
| 2025-06-30 | PATIENCE JOHN | Director | M-Exempt | A | Common Stock | 22,874 | 0.00 | — | 407,486 | D | ↗ |
| 2025-05-20 | Strobeck Matthew | Director | A-Award | A | Restricted Stock Units | 80,525 | 0.00 | — | 80,525 | D | ↗ |
| 2025-05-20 | PATIENCE JOHN | Director | A-Award | A | Stock Options (Right to Buy) | 42,010 | 0.27 | 11.4K | 42,010 | D | ↗ |
| 2025-05-20 | MASSARANY HANY | Director | A-Award | A | Stock Options (Right to Buy) | 42,010 | 0.27 | 11.4K | 42,010 | D | ↗ |
| 2025-05-20 | Kennedy Lawrence T. Jr | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 42,010 | 0.27 | 11.4K | 42,010 | D | ↗ |
| 2025-05-20 | Kayyem Jon Faiz | Director | A-Award | A | Stock Options (Right to Buy) | 42,010 | 0.27 | 11.4K | 42,010 | D | ↗ |
| 2025-05-20 | Franchi Jean M. | Director | A-Award | A | Stock Options (Right to Buy) | 42,010 | 0.27 | 11.4K | 42,010 | D | ↗ |
| 2025-05-19 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 723,239 | 0.34 | 246.6K | 20,918,174 | I | ↗ |
| 2025-05-16 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 4,000,000 | 0.27 | 1.07M | 20,194,935 | I | ↗ |
| 2025-05-13 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 112 | 0.35 | 39.52 | 18,001 | D | ↗ |
| 2025-05-13 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 222 | 0.35 | 78.34 | 156,941 | D | ↗ |
| 2025-05-13 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 238 | 0.35 | 83.99 | 139,052 | D | ↗ |
| 2025-05-13 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 1,887 | 0.35 | 665.92 | 720,384 | D | ↗ |
| 2025-05-13 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 496 | 0.35 | 175.04 | 248,625 | D | ↗ |
| 2025-05-12 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 112 | 0.36 | 40.25 | 18,113 | D | ↗ |
| 2025-05-12 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 223 | 0.36 | 80.15 | 157,163 | D | ↗ |
| 2025-05-12 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 239 | 0.36 | 85.90 | 139,290 | D | ↗ |
| 2025-05-12 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 1,888 | 0.36 | 678.55 | 722,271 | D | ↗ |
| 2025-05-12 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 496 | 0.36 | 178.26 | 249,121 | D | ↗ |
| 2025-05-09 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 602 | 0.00 | — | 1,805 | D | ↗ |
| 2025-05-09 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 1,378 | 0.00 | — | 4,135 | D | ↗ |
| 2025-05-09 | O'Kane Kieran | Officer | M-Exempt | D | Restricted Stock Units | 1,490 | 0.00 | — | 4,468 | D | ↗ |
| 2025-05-09 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 12,212 | 0.00 | — | 724,159 | D | ↗ |
| 2025-05-09 | Cowie Robin Harper | Officer | M-Exempt | A | Common Stock | 3,157 | 0.00 | — | 249,617 | D | ↗ |
| 2025-04-01 | Franchi Jean M. | Director | M-Exempt | A | Common Stock | 26,368 | 0.00 | — | 108,140 | D | ↗ |
| 2025-03-31 | Watts Charles M | Director | M-Exempt | A | Common Stock | 46,686 | 0.00 | — | 421,705 | D | ↗ |
| 2025-03-31 | PATIENCE JOHN | Director | M-Exempt | A | Common Stock | 46,686 | 0.00 | — | 384,612 | D | ↗ |
| 2025-02-20 | Vazquez Chris | Officer | A-Award | A | Stock Options (Right to buy) | 39,664 | 0.92 | 36.5K | 39,664 | D | ↗ |
| 2025-02-20 | Pestano Gary Anthony | Officer | A-Award | A | Stock Options (Right to buy) | 3,810 | 0.92 | 3.5K | 3,810 | D | ↗ |
| 2025-02-20 | O'Kane Kieran | Officer | A-Award | A | Restricted Stock Units | 117,500 | 0.00 | — | 117,500 | D | ↗ |
| 2025-02-20 | Hutton Scott | Director / Officer | A-Award | A | Stock Options (Right to buy) | 425,929 | 0.92 | 392.2K | 425,929 | D | ↗ |
| 2025-02-20 | Cowie Robin Harper | Officer | A-Award | A | Stock Options (Right to buy) | 73,398 | 0.92 | 67.6K | 73,398 | D | ↗ |
| 2025-02-11 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 3,630 | 0.92 | 3.4K | 17,623 | D | ↗ |
| 2025-02-11 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 16,748 | 0.92 | 15.5K | 156,008 | D | ↗ |
| 2025-02-11 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 17,527 | 0.92 | 16.2K | 128,039 | D | ↗ |
| 2025-02-11 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 83,660 | 0.92 | 77.3K | 701,947 | D | ↗ |
| 2025-02-11 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 24,664 | 0.92 | 22.8K | 246,460 | D | ↗ |
| 2025-02-10 | Vazquez Chris | Officer | M-Exempt | A | Common Stock | 9,666 | 0.00 | — | 21,253 | D | ↗ |
| 2025-02-10 | Pestano Gary Anthony | Officer | M-Exempt | A | Common Stock | 45,729 | 0.00 | — | 172,756 | D | ↗ |
| 2025-02-10 | O'Kane Kieran | Officer | M-Exempt | D | Restricted Stock Units | 16,095 | 0.00 | — | 48,286 | D | ↗ |
| 2025-02-10 | Hutton Scott | Director / Officer | M-Exempt | D | Restricted Stock Units | 12,212 | 0.00 | — | 48,848 | D | ↗ |
| 2025-02-10 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 16,095 | 0.00 | — | 48,286 | D | ↗ |
| 2024-11-21 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 100,000 | 1.23 | 122.8K | 31,194,935 | I | ↗ |
| 2024-11-21 | Kennedy Lawrence T. Jr | Director / 10% Owner | P-Purchase | A | Common Stock | 35,000 | 1.16 | 40.6K | 10,411,024 | I | ↗ |
| 2024-11-20 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 200,000 | 1.17 | 234.0K | 31,094,935 | I | ↗ |
| 2024-11-12 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 98 | 1.40 | 137.28 | 11,587 | D | ↗ |
| 2024-11-12 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 207 | 1.40 | 289.97 | 127,027 | D | ↗ |
| 2024-11-12 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 224 | 1.40 | 313.78 | 97,448 | D | ↗ |
| 2024-11-12 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 1,813 | 1.40 | 2.5K | 532,979 | D | ↗ |
| 2024-11-12 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 471 | 1.40 | 659.78 | 203,336 | D | ↗ |
| 2024-11-11 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 105 | 1.39 | 146.04 | 11,685 | D | ↗ |
| 2024-11-11 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 220 | 1.39 | 306.00 | 127,234 | D | ↗ |
| 2024-11-11 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 238 | 1.39 | 331.03 | 97,672 | D | ↗ |
| 2024-11-11 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 1,927 | 1.39 | 2.7K | 534,792 | D | ↗ |
| 2024-11-11 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 500 | 1.39 | 695.45 | 203,807 | D | ↗ |
| 2024-11-08 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 602 | 0.00 | — | 3,008 | D | ↗ |
| 2024-11-08 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 1,378 | 0.00 | — | 6,891 | D | ↗ |
| 2024-11-08 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 1,490 | 0.00 | — | 97,910 | D | ↗ |
| 2024-11-08 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 12,212 | 0.00 | — | 536,719 | D | ↗ |
| 2024-11-08 | Cowie Robin Harper | Officer | M-Exempt | A | Common Stock | 3,156 | 0.00 | — | 204,307 | D | ↗ |
| 2024-11-06 | Kennedy Lawrence T. Jr | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 1.36 | 27.2K | 10,376,024 | I | ↗ |
| 2024-11-05 | Strobeck Matthew | Director | P-Purchase | A | Common Stock | 4,000 | 1.40 | 5.6K | 89,673 | I | ↗ |
| 2024-11-05 | SCHULER JACK W | Director / 10% Owner | P-Purchase | A | Common Stock | 100,253 | 1.36 | 136.6K | 30,894,935 | I | ↗ |
| 2024-11-05 | PATIENCE JOHN | Director | P-Purchase | A | Common Stock | 75,000 | 1.38 | 103.7K | 2,153,298 | I | ↗ |
| 2024-11-05 | MASSARANY HANY | Director | P-Purchase | A | Common Stock | 22,500 | 1.37 | 30.9K | 53,364 | I | ↗ |
| 2024-11-05 | Kennedy Lawrence T. Jr | Director / 10% Owner | P-Purchase | A | Common Stock | 51,200 | 1.37 | 69.9K | 10,356,024 | I | ↗ |
| 2024-08-12 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 54 | 1.57 | 84.88 | 11,188 | — | ↗ |
| 2024-08-12 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 111 | 1.57 | 174.48 | 126,076 | — | ↗ |
| 2024-08-12 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 120 | 1.57 | 188.63 | 89,628 | — | ↗ |
| 2024-08-12 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 963 | 1.57 | 1.5K | 518,368 | — | ↗ |
| 2024-08-12 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 251 | 1.57 | 394.55 | 191,151 | — | ↗ |
| 2024-08-09 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 155 | 1.60 | 248.16 | 11,242 | — | ↗ |
| 2024-08-09 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 320 | 1.60 | 512.32 | 126,187 | — | ↗ |
| 2024-08-09 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 345 | 1.60 | 552.35 | 89,748 | — | ↗ |
| 2024-08-09 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 2,781 | 1.60 | 4.5K | 519,331 | — | ↗ |
| 2024-08-09 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 724 | 1.60 | 1.2K | 191,402 | — | ↗ |
| 2024-08-08 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 602 | 0.00 | — | 3,610 | — | ↗ |
| 2024-08-08 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 1,379 | 0.00 | — | 8,269 | — | ↗ |
| 2024-08-08 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 1,489 | 0.00 | — | 90,093 | — | ↗ |
| 2024-08-08 | Hutton Scott | Director / Officer | M-Exempt | D | Restricted Stock Units | 12,212 | 0.00 | — | 73,272 | — | ↗ |
| 2024-08-08 | Cowie Robin Harper | Officer | M-Exempt | D | Restricted Stock Units | 3,157 | 0.00 | — | 18,940 | — | ↗ |
| 2024-07-16 | Watts Charles M | Director | M-Exempt | A | Common Stock | 26,368 | 0.00 | — | 375,019 | — | ↗ |
| 2024-05-23 | Vazquez Chris | Officer | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 22 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | Strobeck Matthew | Director | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 7,392 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | SCHULER JACK W | Director / 10% Owner | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 2,174 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | Pestano Gary Anthony | Officer | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 22 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | PATIENCE JOHN | Director | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 5,435 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 13,080 | 0.00 | — | 88,604 | — | ↗ |
| 2024-05-23 | Kennedy Lawrence T. Jr | Director / 10% Owner | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 65,218 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 26,120 | 0.00 | — | 509,900 | — | ↗ |
| 2024-05-23 | Cowie Robin Harper | Officer | M-Exempt | A | Common Stock | 13,080 | 0.00 | — | 188,969 | — | ↗ |
| 2024-05-21 | Watts Charles M | Director | A-Award | A | Restricted Stock Units | 46,686 | 0.00 | — | 46,686 | — | ↗ |
| 2024-05-21 | Strobeck Matthew | Director | A-Award | A | Restricted Stock Units | 53,726 | 0.00 | — | 53,726 | — | ↗ |
| 2024-05-21 | SCHULER JACK W | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | PATIENCE JOHN | Director | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | MASSARANY HANY | Director | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | Kennedy Lawrence T. Jr | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | Kayyem Jon Faiz | Director | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | Franchi Jean M. | Director | A-Award | A | Stock Options (Right to Buy) | 37,050 | 1.57 | 58.2K | 37,050 | — | ↗ |
| 2024-05-21 | Cowie Robin Harper | Officer | M-Exempt | D | Stock Options (Right to buy) | 4,209 | 0.42 | 1.8K | 0 | — | ↗ |
| 2024-05-09 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 244 | 1.48 | 361.00 | 9,915 | — | ↗ |
| 2024-05-09 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 434 | 1.48 | 642.10 | 124,248 | — | ↗ |
| 2024-05-09 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 468 | 1.48 | 692.41 | 75,524 | — | ↗ |
| 2024-05-09 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 3,764 | 1.48 | 5.6K | 483,780 | — | ↗ |
| 2024-05-09 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 980 | 1.48 | 1.4K | 171,680 | — | ↗ |
| 2024-05-08 | Vazquez Chris | Officer | M-Exempt | D | Restricted Stock Units | 601 | 0.00 | — | 4,212 | — | ↗ |
| 2024-05-08 | Pestano Gary Anthony | Officer | M-Exempt | D | Restricted Stock Units | 1,378 | 0.00 | — | 9,648 | — | ↗ |
| 2024-05-08 | O'Kane Kieran | Officer | M-Exempt | A | Common Stock | 1,489 | 0.00 | — | 75,992 | — | ↗ |
| 2024-05-08 | Hutton Scott | Director / Officer | M-Exempt | A | Common Stock | 12,212 | 0.00 | — | 487,544 | — | ↗ |
| 2024-05-08 | Cowie Robin Harper | Officer | M-Exempt | A | Common Stock | 3,157 | 0.00 | — | 172,660 | — | ↗ |
| 2024-04-05 | Vazquez Chris | Officer | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 22 | 0.00 | — | 22 | — | ↗ |
| 2024-04-05 | Strobeck Matthew | Director | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 7,392 | 0.00 | — | 7,392 | — | ↗ |
| 2024-04-05 | SCHULER JACK W | Director / 10% Owner | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 2,174 | 0.00 | — | 2,174 | — | ↗ |
| 2024-04-05 | Pestano Gary Anthony | Officer | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 22 | 0.00 | — | 22 | — | ↗ |
| 2024-04-05 | PATIENCE JOHN | Director | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 5,435 | 0.00 | — | 5,435 | — | ↗ |
| 2024-04-05 | O'Kane Kieran | Officer | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 327 | 0.00 | — | 327 | — | ↗ |
| 2024-04-05 | Kennedy Lawrence T. Jr | Director / 10% Owner | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 43,478 | 0.00 | — | 43,478 | — | ↗ |
| 2024-04-05 | Hutton Scott | Director / Officer | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 653 | 0.00 | — | 653 | — | ↗ |
| 2024-04-05 | Cowie Robin Harper | Officer | A-Award | A | Series A Non-Voting Convertible Preferred Stock | 327 | 0.00 | — | 327 | — | ↗ |
| 2024-04-01 | Watts Charles M | Director | M-Exempt | A | Common Stock | 134,262 | 0.00 | — | 348,651 | — | ↗ |
| 2024-02-21 | Vazquez Chris | Officer | A-Award | A | Stock Options (Right to buy) | 14,280 | 1.46 | 20.8K | 14,280 | — | ↗ |
| 2024-02-21 | Pestano Gary Anthony | Officer | A-Award | A | Stock Options (Right to buy) | 3,690 | 1.46 | 5.4K | 3,690 | — | ↗ |
| 2024-02-21 | O'Kane Kieran | Officer | A-Award | A | Stock Options (Right to buy) | 35,307 | 1.46 | 51.5K | 35,307 | — | ↗ |
| 2024-02-21 | Hutton Scott | Director / Officer | A-Award | A | Stock Options (Right to buy) | 180,926 | 1.46 | 264.2K | 180,926 | — | ↗ |
| 2024-02-21 | Cowie Robin Harper | Officer | A-Award | A | Stock Options (Right to buy) | 62,358 | 1.46 | 91.0K | 62,358 | — | ↗ |
| 2024-02-12 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 922 | 1.66 | 1.5K | 9,548 | — | ↗ |
| 2024-02-12 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 5,022 | 1.66 | 8.4K | 123,250 | — | ↗ |
| 2024-02-12 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 5,412 | 1.66 | 9.0K | 68,005 | — | ↗ |
| 2024-02-12 | Hutton Scott | Director / Officer | S-Sale | D | Common Stock | 29,708 | 1.66 | 49.5K | 465,011 | — | ↗ |
| 2024-02-12 | Cowie Robin Harper | Officer | S-Sale | D | Common Stock | 8,699 | 1.66 | 14.5K | 169,410 | — | ↗ |
| 2024-02-09 | Vazquez Chris | Officer | S-Sale | D | Common Stock | 1,077 | 1.92 | 2.1K | 10,470 | — | ↗ |
| 2024-02-09 | Pestano Gary Anthony | Officer | S-Sale | D | Common Stock | 5,862 | 1.92 | 11.2K | 128,272 | — | ↗ |
| 2024-02-09 | O'Kane Kieran | Officer | S-Sale | D | Common Stock | 6,319 | 1.92 | 12.1K | 73,417 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-100.9K
Shares Outstanding
7.55M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Scott Hutton President and Chief Executive Officer | 643.4K | — | 356.8K | 524.4K | 710.3K | 3.5K | 2.24M | 39.37% | ↗ |
| 2 | 2025 | Kieran O’Kane Chief Commercial Officer | 443.0K | — | 108.2K | 159.0K | 293.5K | 3.5K | 1.01M | 26.53% | ↗ |
| 3 | 2025 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 443.4K | — | 108.2K | 159.0K | 244.7K | 6.7K | 962.0K | 27.78% | ↗ |
| 4 | 2024 | Scott Hutton President and Chief Executive Officer | 588.9K | — | 419.1K | 852.0K | 223.6K | 1.3K | 2.08M | 60.97% | ↗ |
| 5 | 2024 | Kieran O’Kane Chief Commercial Officer | 401.6K | — | 128.1K | 233.5K | 137.5K | — | 900.6K | 40.15% | ↗ |
| 6 | 2024 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 405.9K | — | 128.1K | 224.7K | 115.6K | 1.3K | 875.5K | 40.30% | ↗ |
| 7 | 2023 | Scott Hutton President and Chief Executive Officer | 515.0K | — | 1.44M | 233.6K | 98.1K | 1.9K | 2.29M | 73.15% | ↗ |
| 8 | 2023 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 355.0K | — | 372.8K | 81.3K | 33.8K | 1.5K | 844.4K | 53.78% | ↗ |
| 9 | 2023 | Kieran O’Kane Chief Commercial Officer | 335.0K | — | 234.4K | 45.6K | 57.4K | 205.00 | 672.7K | 41.63% | ↗ |
| 10 | 2022 | Scott Hutton President and Chief Executive Officer | 515.0K | — | 1.44M | 680.5K | 114.9K | 2.1K | 2.75M | 77.06% | ↗ |
| 11 | 2022 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 350.1K | — | 372.7K | 231.9K | 39.1K | 1.6K | 995.5K | 60.74% | ↗ |
| 12 | 2022 | Ryan Siurek Chief Accounting Officer | 300.0K | — | 192.5K | 178.4K | 30.1K | 2.2K | 703.2K | 52.75% | ↗ |
| 13 | 2021 | Scott Hutton President and Chief Executive Officer | 490.3K | — | — | 4.07M | 95.9K | 102.00 | 4.65M | 87.40% | ↗ |
| 14 | 2021 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 317.9K | — | — | 1.18M | 31.0K | 163.00 | 1.53M | 77.15% | ↗ |
| 15 | 2021 | Ryan Siurek Chief Accounting Officer | 294.9K | — | — | 643.4K | — | — | 938.3K | 68.57% | ↗ |
| 16 | 2020 | Scott Hutton President and Chief Executive Officer | 364.2K | — | — | — | 167.6K | 71.00 | 1.58M | 0.00% | ↗ |
| 17 | 2020 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 271.0K | — | — | — | 104.1K | 143.00 | 996.5K | 0.00% | ↗ |
| 18 | 2020 | Kieran O’Kane Chief Commercial Officer | 239.0K | 2.0K | — | 414.5K | 68.1K | 917.00 | 724.5K | 57.20% | ↗ |
| 19 | 2019 | Scott Hutton President and Chief Executive Officer | 298.5K | — | — | — | — | — | 336.8K | 0.00% | ↗ |
| 20 | 2019 | Robin Harper Cowie Chief Financial Officer, Secretary and Treasurer | 263.5K | — | — | — | — | — | 293.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Scott Hutton | President, Chief Executive Officer & Director | 1M | male |
| Kieran O'Kane | Chief Commercial Officer | 740.1K | male |
| Robin Harper Cowie | Chief Financial Officer, Secretary & Treasurer | 694.8K | female |
| James R. Jett | Co-Chief Medical Officer | — | — |
| Jessica Olbricht | Senior Director of Human Resources | — | female |
| Michael N. Kammer | Head of Radiomics | — | — |
| Bobbi Coffin | Chief Growth Officer | — | female |
| Steven C. Springmeyer | Co-Chief Medical Officer | — | — |
| Gary Anthony Pestano | Chief Scientific Officer | — | — |
| Heinrich Roder D.Phil | Founder & Chief Technology Officer | — | — |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BDSX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
